poisar

Stocks · News reference

Genprex Reports Third Quarter 2026 Financial Results

Fiscal.ai

Genprex, Inc. reported its financial results for the third quarter of 2026, noting continued zero revenue and an increase in operating losses.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Genprex, Inc. (GNPX)

    Filed: 2026-11-04 AccNo: 0001437749-26-034764 Size: 172 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits